Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03679026
Other study ID # CODIM-FLP-16 261
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date August 22, 2017
Est. completion date December 21, 2024

Study information

Verified date April 2024
Source Jewish General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Cognition and locomotion are two human abilities controlled by the brain. Their decline is highly prevalent with aging, and is greater than the simple sum of their respective prevalence, suggesting a complex age-related interplay between cognition and locomotion. Recently, a systematic review and meta-analysis has provided evidence that poor gait performance predicts dementia and, in particular, has demonstrated that "motoric cognitive risk" (MCR) syndrome, which has been described in cognitively healthy individuals and combines subjective cognitive complaint with objective slow gait speed, is a pre-dementia syndrome. The uniqueness of "motoric cognitive risk" (MCR)syndrome is that it does not rely on a complex evaluation or laboratory investigations. Thus, it is easy to apply in population-based settings. The overall objective of the proposal is to examine the epidemiology of the newly reported "motoric cognitive risk" (MCR) syndrome, in the Quebec population using the database of the NuAge study.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1461
Est. completion date December 21, 2024
Est. primary completion date August 21, 2021
Accepts healthy volunteers No
Gender All
Age group 45 Years to 85 Years
Eligibility Inclusion Criteria: - Individuals eligible for this study will be participants of the NuAge study Exclusion Criteria: - Individuals not eligible for the NuAge study - dementia - mobility disability - no information about cognitive complaint - no measure of walking speed

Study Design


Intervention

Other:
Summarize of participants' characteristics using means and standard deviations or frequencies and percentages
Participants' baseline characteristics will be summarized using means and standard deviations or frequencies and percentages, as appropriate.

Locations

Country Name City State
Canada Jewish General Hospital Montréal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Jewish General Hospital

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cardio-vascular risk factors and diseases assessed using reported health condition medical history 1 day
Secondary Cardio-vascular risk factors and diseases assessed using physical examination: BMI body mass index 1 day
Secondary Cardio-vascular risk factors and diseases assessed using physical examination: HW ratio hip-waist ratio 1 day
Secondary Cardio-vascular risk factors and diseases assessed using physical examination: blood pressure (value of systolic, diastolic when participants are seated in an upright position in a chair) 1 day
Secondary Disability and functional limitations Disability and functional limitations : ADL (activities of daily life) 1 day
Secondary Disability and functional limitations Disability and functional limitations : IADL (instrumental activities of daily life) 1 day
Secondary Disability and functional limitations History of falls during the past 12 months 12 months
Secondary Depression measured by the 10 items of the Center for Epidemiological Studies Short Depression Scale. Participants with a score of 10 or greater are considered as depressed. Scores with more than 2 missing items will be excluded. 1 day
Secondary Cognitive performance Prospective Memory Test (PMT) 1 day
Secondary Cognitive performance Stroop Neurological Screening Test 1 day
Secondary Cognitive performance Controlled Oral Word Association Test (FAS) 1 day
Secondary Cognitive performance Choice Reaction Time Test (CRT) 1 day
Secondary physical and mental health Number of drugs daily taken 1 day
Secondary physical and mental health Self-perception of health and mental health 1 day
Secondary Physical performance Muscle strength estimated using the handgrip strength 1 day
Secondary Physical performance five-time sit-to-stand test 1 day
Secondary Physical performance Physical Activity Scale for the Elderly, scored between 0 and 400, low scores indicate sarcopenia 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)